Teva Pharmaceutical Industries Limited Copy of Sanofi-Aventis (France) Blood Thinner is Close According to Analyst

Reuters -- A second generic version of Sanofi-Aventis's (SASY.PA) blood-clot drug Lovenox is likely to reach the U.S. market this year, intensifying competition and pushing down prices, a leading analyst said on Thursday.